1989
DOI: 10.2337/diabetes.38.10.1258
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
51
2

Year Published

1990
1990
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 138 publications
(58 citation statements)
references
References 0 publications
5
51
2
Order By: Relevance
“…Vascular dysfunction induced by diabetes includes hemodynamic changes and increased transvascular flux of macromolecules in both humans and animals, and numerous lines of evidence attest to a multifactorial pathogenesis (29). Results of our studies have linked increased flux of glucose via the sorbitol (polyol) pathway to vascular blood flow increases and hyperpermeability, because inhibitors of the two enzymes comprising this metabolic pathway block these vascular changes (39,40). Other mechanisms reported to have important roles in the pathogenesis of diabetic vascular dysfunction include increased diacylglycerol-protein kinase C activation (7,16), changes in intracellular NADH/NAD + coupled to oxidation of sorbitol to fructose in the second step of the sorbitol pathway (50), and increased formation of advanced glycation end products (4,5).…”
Section: Introductionmentioning
confidence: 81%
“…Vascular dysfunction induced by diabetes includes hemodynamic changes and increased transvascular flux of macromolecules in both humans and animals, and numerous lines of evidence attest to a multifactorial pathogenesis (29). Results of our studies have linked increased flux of glucose via the sorbitol (polyol) pathway to vascular blood flow increases and hyperpermeability, because inhibitors of the two enzymes comprising this metabolic pathway block these vascular changes (39,40). Other mechanisms reported to have important roles in the pathogenesis of diabetic vascular dysfunction include increased diacylglycerol-protein kinase C activation (7,16), changes in intracellular NADH/NAD + coupled to oxidation of sorbitol to fructose in the second step of the sorbitol pathway (50), and increased formation of advanced glycation end products (4,5).…”
Section: Introductionmentioning
confidence: 81%
“…Bar, 0.5 gm any effect of aldose reductase inhibitors on increased mesangial fractional volume in diabetic rats [12], another study demonstrated that these drugs could prevent mesangial expansion in diabetic rats on a high protein diet [11]. Recently, Mauer et al reported that sorbinil can decrease GBM width in normal rats, although the mechanism is not known [8]. The disparity in effects of aldose reductase inhibitors in different tissues indicates that the polyol pathway may not be involved in the pathogenesis of GBM thickening in galactosaemic rats, even though it appears to have a role in the basement membrane thickening that occurs in the retinal and cerebral cortical capillaries of these animals.…”
Section: Labelling Densities Of Basement Membrane Componentsmentioning
confidence: 99%
“…The enzyme, aldose reductase has been immunocytochemically localized in glomerular podocytes [3] and cultured mesangial cells [4], and elevated concentrations of galactitol in the renal cortex of galactosaemic rats [5] and sorbitol in the renal papillae in diabetes [6] have been described. Although several investigators have shown that administration of aldose reductase inhibitors prevents renal hyperperfusion and increase in glomerular filtration rate in diabetic rats [7][8][9], one report failed to show such effect in these animals [10]. However, aldose reductase inhibition does not prevent glomerular basement membrane (GBM) thickening in diabetic rats [11][12][13].To examine further the relationship of the polyol pathway to diabetic nephropathy, we fed rats a diet containing 30% by weight galactose for nine months.…”
mentioning
confidence: 99%
“…Because of the localization and functions in the blood vessel, endothelial cells are considered candidates primarily involved in the pathogen-esis of diabetic vascular complications. Acute exposure to high glucose in nondiabetic individuals would induce vasodilation, owing to an increase of endothelium-derived nitric oxide (NO) formation [Tilton et al, 1989[Tilton et al, , 1992Sandeman et al, 1996;Houben et al, 1993;Williamson et al, 1993]. However, impairment of endothelium-dependent vascular relaxation in diabetic animals and humans has been shown [Durante et al, 1988;Tesfamariam et al, 1991;Tesfamariam, 1994].…”
mentioning
confidence: 99%